MYLK and metabolic dysfunction-associated steatotic liver disease: Taken together, the results of our study and those of others40 suggest that the loss of arginase activity, resulting in increased nitric oxide levels and through so far not fully understood mechanism in changes in MYLK and concentrations of tight junction proteins, may be key factors in the development of intestinal barrier dysfunction in the setting of NAFLD.